{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:25:57Z","timestamp":1793388357851,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00415-005-5002-7","type":"journal-article","created":{"date-parts":[[2005,10,27]],"date-time":"2005-10-27T15:24:01Z","timestamp":1130426641000},"page":"v3-v9","source":"Crossref","is-referenced-by-count":216,"title":["The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage"],"prefix":"10.1007","volume":"252","author":[{"given":"Wolfgang","family":"Br\u00fcck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5002_CR1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuron.2005.03.018","volume":"46","author":"Aktas","year":"2005","unstructured":"Aktas O, Smorodchenko A, Brocke S, Infante-Duarte C, Topphoff US, Vogt J, Prozorovski T, Meier S, Osmanova V, Pohl E, Bechmann I, Nitsch R, Zipp F (2005) Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 46:421\u2013432","journal-title":"Neuron"},{"key":"5002_CR2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archneur.60.8.1073","volume":"60","author":"Barkhof","year":"2003","unstructured":"Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S,Geurts J, Polman CH, van der Valk P (2003) Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 60:1073\u20131081","journal-title":"Arch Neurol"},{"key":"5002_CR3","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.4049\/jimmunol.162.11.6303","volume":"162","author":"Besser","year":"1999","unstructured":"Besser M, Wank R (1999) Cutting edge: clonally restricted production of the neurotrophin brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1\/Th2 polarised expression of their receptors. J Immunol 162:6303\u20136306","journal-title":"J Immunol"},{"key":"5002_CR4","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/brain\/123.6.1174","volume":"123","author":"Bitsch","year":"2000","unstructured":"Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123:1174\u20131183","journal-title":"Brain"},{"key":"5002_CR5","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1084\/jem.184.6.2361","volume":"184","author":"D\u2019Souza","year":"1996","unstructured":"D\u2019Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 184:2361\u20132370","journal-title":"J Exp Med"},{"key":"5002_CR6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/120.3.393","volume":"120","author":"Ferguson","year":"1997","unstructured":"Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120:393\u2013399","journal-title":"Brain"},{"key":"5002_CR7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.189.5.865","volume":"189","author":"Kerschensteiner","year":"1999","unstructured":"Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R (1999) Activated human T cells, B cells and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189:865\u2013870","journal-title":"J Exp Med"},{"key":"5002_CR8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.10446","volume":"53","author":"Kerschensteiner","year":"2003","unstructured":"Kerschensteiner M, Stadelmann C, Dechant G, Wekerle H, Hohlfeld R (2003) Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol 53:292\u2013304","journal-title":"Ann Neurol"},{"key":"5002_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","volume":"157","author":"Kornek","year":"2000","unstructured":"Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267\u2013276","journal-title":"Am J Pathol"},{"key":"5002_CR10","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/brain\/awf235","volume":"125","author":"Kuhlmann","year":"2002","unstructured":"Kuhlmann T, Lingfield G, Bitsch A, Schuchardt J, Bruck W (2002) Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125:2202\u20132212","journal-title":"Brain"},{"key":"5002_CR11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/brain\/123.2.308","volume":"123","author":"Lovas","year":"2000","unstructured":"Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S (2000) Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123:308\u2013317","journal-title":"Brain"},{"key":"5002_CR12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"Lucchinetti","year":"2000","unstructured":"Lucchinetti, C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"5002_CR13","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1093\/brain\/awf254","volume":"125","author":"Matysiak","year":"2002","unstructured":"Matysiak M, Jurewicz A, Jaskolski D, Selmaj K (2002) TRAIL induces death of human oligodendrocytes isolated from adult brain. Brain 125:2469\u20132480","journal-title":"Brain"},{"key":"5002_CR14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4049\/jimmunol.168.1.458","volume":"68","author":"Mead","year":"2002","unstructured":"Mead RJ, Singhrao SK, Neal JW, Lassmann H, Morgan BP (2002) The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J Immunol 68:458\u2013465","journal-title":"J Immunol"},{"key":"5002_CR15","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/1521-4141(200012)30:12<3623::AID-IMMU3623>3.0.CO;2-F","volume":"30","author":"Medana","year":"2000","unstructured":"Medana IM, Gallimore A,Oxenius A, Martinic MM, Wekerle H, Neumann H (2000) MHC class I-restricted killing of neurons by virus-specific CD8 + T lymphocytes is effected through the Fas\/FasL, but not the perforin pathway. Eur J Immunol 30:3623\u20133633","journal-title":"Eur J Immunol"},{"key":"5002_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/135245859800400203","volume":"4","author":"Mews","year":"1998","unstructured":"Mews I, Bergmann M, Bunkowski S, Gullotta F, Bruck W (1998) Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler 4:55\u201362","journal-title":"Mult Scler"},{"key":"5002_CR17","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1523\/JNEUROSCI.18-18-07306.1998","volume":"18","author":"Murray","year":"1998","unstructured":"Murray PD, McGavern DB, Lin X, Njenga MK, Leibowitz J, Pease LR, Rodriguez M (1998) Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci 18:7306\u20137314","journal-title":"J Neurosci"},{"key":"5002_CR18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0166-2236(02)02154-9","volume":"25","author":"Neumann","year":"2002","unstructured":"Neumann H, Medana IM, Bauer J, Lassmann H (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 25:313\u2013319","journal-title":"Trends Neurosci"},{"key":"5002_CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.185.2.305","volume":"185","author":"Neumann","year":"1997","unstructured":"Neumann H, Schmidt H, Cavalie A, Jenne D, Wekerle H (1997) Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. J Exp Med 185:305\u2013316","journal-title":"J Exp Med"},{"key":"5002_CR20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0161-5890(98)00049-2","volume":"35","author":"Okuda","year":"1998","unstructured":"Okuda Y, Bernard CC, Fujimura H, Yanagihara T, Sakoda S (1998) Fas has a crucial role in the progression of experimental autoimmune encephalomyelitis. Mol Immunol 35:317\u2013326","journal-title":"Mol Immunol"},{"key":"5002_CR21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","volume":"50","author":"Peterson","year":"2001","unstructured":"Peterson JW, Bo L, Mork S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389\u2013400","journal-title":"Ann Neurol"},{"key":"5002_CR22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/71555","volume":"6","author":"Pitt","year":"2000","unstructured":"Pitt D, Werner P, Raine CS (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6:67\u201370","journal-title":"Nat Med"},{"key":"5002_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/jaut.1999.0321","volume":"13","author":"Pouly","year":"1999","unstructured":"Pouly S, Antel JP (1999) Multiple sclerosis and central nervous system demyelination. J Autoimmun 13:297\u2013306","journal-title":"J Autoimmun"},{"key":"5002_CR24","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/brain\/120.12.2149","volume":"120","author":"Redford","year":"1997","unstructured":"Redford EJ, Kapoor R, Smith KJ (1997) Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120:2149\u20132157","journal-title":"Brain"},{"key":"5002_CR25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0165-5728(96)00236-6","volume":"74","author":"Rubesa","year":"1997","unstructured":"Rubesa G, Podack ER, Sepcic J, Rukavina D (1997) Increased perforin expression in multiple sclerosis patients during exacerbation of disease in peripheral blood lymphocytes. J Neuroimmunol 74:198\u2013204","journal-title":"J Neuroimmunol"},{"key":"5002_CR26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.96","volume":"49","author":"Smith","year":"2001","unstructured":"Smith KJ, Kapoor R, Hall SM, Davies M (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49:470\u2013476","journal-title":"Ann Neurol"},{"key":"5002_CR27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/brain\/awf015","volume":"125","author":"Stadelmann","year":"2002","unstructured":"Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125:75\u201385","journal-title":"Brain"},{"key":"5002_CR28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"Trapp","year":"1998","unstructured":"Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278\u2013285","journal-title":"N Engl J Med"},{"key":"5002_CR29","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.158.6.2756","volume":"158","author":"Vergelli","year":"1997","unstructured":"Vergelli M, Hemmer B, Muraro PA, Tranquill L, Biddison WE, Sarin A, Mc-Farland HF, Martin R (1997) Human autoreactive CD4 + T cell clones use perforin- or Fas\/Fas ligand-mediated pathways for target cell lysis. J Immunol 158:2756\u20132761","journal-title":"J Immunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-5002-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-005-5002-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-5002-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T06:36:10Z","timestamp":1683268570000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-005-5002-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":29,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["5002"],"URL":"https:\/\/doi.org\/10.1007\/s00415-005-5002-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}